Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma

Genes Chromosomes and Cancer

Volumn 15, Issue 4, 1996, Pages 217-222

  Iolascon, Achille ^a   Faienza, Maria Felicia ^a   Coppola, Brigida ^a   Rosolen, Angelo ^b   Basso, Giuseppe ^c   Della Ragione, Fulvio ^d   Schettini, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE;

ADOLESCENT; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; ENZYME INHIBITION; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUSCLE CELL; POINT MUTATION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; BASE SEQUENCE; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; TUMOR CELLS, CULTURED;

EUKARYOTA;

EID: 0029929274     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199604)15:4<217::AID-GCC3>3.0.CO;2-4     Document Type: Article

References (26)

1. Anand G, Shapiro DN, Dickman PS, Prochownick EV (1994) Rhabdomyosarcoma do not contain mutations in the DNA binding domains of the myogenic transcription factors. J Clin Invest 93: 5-9.
2. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, Van der Riet P, Blaugrund JE, Sidransky D (1994) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265: 415-417.
3. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinsten CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 8:27-32.
4. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG (1994) Fusion of Pax7 to FKHR by the variant t(1:13p36:q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54:2869-2872.
5. De Giovanni C, Nanni P, Nicoletti G, Ceccarelli C, Scotland K, Landuzzi L, Lollini PL (1989) Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA) Anticancer Res 9:1943-1950.
6. Galili N, Davis RJ, Frederickes WI, Mukhopadhyay S, Rauscher F 3rd, Emanuel BS, Rovera G, Barr FG (1993) Fusion of a fork head domain gene to Pax3 in the solid alveolar rhabdomyosarcoma. Nature Genet 5:230-235.
7. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8:2939-2945.
8. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
9. Hannon GJ, Beach D (1994) CDKN2B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261.
10. Hartwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266:1821-1828.
11. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nature Genet 8:15-21.
12. Iolascon A, Parrella T, Perrotta S, Guardamagna O, Coates PM, Sartore M, Surrey S, Fortina P (1994) Rapid detection of medium-chain Acyl-CoA dehydrogenase gene mutations by non-radioactive, single-strand conformation polymorphism minigels. J Med Genet 31:551-554.
13. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stocken E, Day RS III, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
14. Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, Inoue H, Fukuma H (1994) Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor. Cancer 73:2499-2505.
15. Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK, Kamb A (1995) CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 10:1061-1067.
16. Maniatis T, Fritsch E, Sambrook J (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
17. McAllister RM, Melnyk J, Finklestein JZ, Adams EC Jr, Gardner MB (1969) Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 55:520-526.
18. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1:686-692.
19. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y (1994) Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54:3396-3397.
20. Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH, Harris CC (1994) Mutations and altered expression of CDKN2A in human cancer. Proc Natl Acad Sci USA 91:11045-11049.
21. /MTS2 and CDKN2C genes in primary and metastatic lung cancer. Cancer Res 55:1448-1451.
22. Pines J (1995) Cyclins, CDKs and cancer. Semin Cancer Biol 6:63-72.
23. Serra A, Gottardi E, Della Ragione F, Saglio G, Iolascon A (1995) Involvement of the cyclin-dependent kinase 4 inhibitor (CDK4I) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukemia. Br J Haematol 91:625-629.
24. Spruck CH, Gonzales-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzales F, Tasi YC, Jones PA (1994) p16 Gene in uncultured tumors. Science 370:183-184.
25. Takeushi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen WG, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler HP (1995) Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and CDKN2C genes in acute lymphoblastic leukemia of childhood. Blood 66:755-760.
26. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M (1995) Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytoma. Cancer Res 55:20-25.